Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV | Haematologica
OPTIM-Imatinib Trial: Imatinib Dose Optimization in CML | Research To Practice
Imatinib in the treatment of chronic myeloid leukemia: current perspec | BLCTT
Toxicity and Reasons for Imatinib Dose Reduction in 16 Patients | Download Table
Gleevec: Package Insert / Prescribing Information - Drugs.com
Glivec Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
PDF) Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance | Michelina Santopietro - Academia.edu
OPTIM-Imatinib Trial: Imatinib Dose Optimization in CML | Research To Practice
Imatinib - wikidoc
GLEEVEC (imatinib) for Ph+ Chronic Myeloid Leukemia - Cancer Therapy Advisor
A. Event-free survival after imatinib dose escalation by type of... | Download Scientific Diagram
A Ten-Year Experience of Treating Chronic Myeloid Leukemia in Rural Rwanda: Outcomes and Insights for a Changing Landscape | JCO Global Oncology
Imatinib, Dose :400mg at best price in Nagpur | ID: 18903324330
PDF] Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study. | Semantic Scholar
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients – final analysis of a randomized, multicenter, phase III trial | Haematologica
Gleevec: Package Insert / Prescribing Information - Drugs.com
GLEEVEC Dosage & Rx Info | Uses, Side Effects
Imatinib - Wikipedia
Gleevec (imatinib) Cancer Medication - Cancer Health
GLEEVEC (imatinib) for Ph+ Chronic Myeloid Leukemia - Cancer Therapy Advisor
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial - The Lancet